5:50 PM
 | 
Nov 05, 2013
 |  BC Extra  |  Top Story

Endo to acquire Paladin Labs

Endo Health Solutions Inc. (NASDAQ:ENDP) is acquiring fellow specialty pharma Paladin Labs Inc. (TSX:PLB) in a cash and stock deal that the companies said values Paladin at C$77 per share, or about US$1.6 billion. Paladin shareholders will receive 1.6331 shares in the combined company, which is about 98% of the total purchase price, and C$1.16 in cash for each Paladin share held....

Read the full 298 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >